Ontogeny of plasma cytokine and chemokine concentrations across the first week of human life. (December 2021)

• Record Type: Journal Article
• Authors: Smolen, Kinga K.; Plotkin, Alec L.; Shannon, Casey P.; Idoko, Olubukola T.; Pak, Jensen; Darboe, Alansana; van Haren, Simon; Amenyogbe, Nelly; Tebbutt, Scott J.; Kollmann, Tobias R.; Kampmann, Beate; Ozonoff, Al; Levy, Ofer; Odumade, Oludare A.
• Is Part Of: Cytokine. Volume 148(2021)
• Publication Date: 2021-12
• Subjects: Cytokines -- Chemokines -- Ontogeny -- Infant immune -- Innate immune; DOL day of life -- EPIC Expanded Program on Immunization Consortium -- HIPC Human Immune Project Consortium -- Ig immunoglobulin -- IL interleukin -- TGF-β transforming growth factor beta -- TNF tumor necrosis factor -- CXCL C-X-C motif ligand -- CCL CC chemokine ligands -- VEGF vascular endothelial growth factor -- IFN interferon -- G-CSF granulocyte colony-stimulating factor -- GM-CSF granulocyte-macrophage colony-stimulating factor -- FGF fibroblast growth factor -- Treg Regulatory T cell; Cytokines -- Periodicals; 571.844
• DOI: 10.1016/j.cyto.2021.155704
• Languages: English
• ISSNs: 1043-4666

Abstract

Graphical abstract: Abstract: Introduction/background & aims: Early life is marked by distinct and rapidly evolving immunity and increased susceptibility to infection. The vulnerability of the newborn reflects development of a complex immune system in the face of rapidly changing demands during the transition to extra-uterine life. Cytokines and chemokines contribute to this dynamic immune signaling network and can be altered by many factors, such as infection. Newborns undergo dynamic changes important to health and disease, yet there is limited information regarding human neonatal plasma cytokine and chemokine concentrations over the first week of life. The few available studies are limited by small sample size, cross-sectional study design, or focus on perturbed host states like severe infection or prematurity. To characterize immune ontogeny among healthy full-term newborns, we assessed plasma cytokine and chemokine concentrations across the first week of life in a robust longitudinal cohort of healthy, full-term African newborns. Methods: We analyzed a subgroup of a cohort of healthy newborns at the Medical Research Council Unit in The Gambia (West Africa; N = 608). Peripheral blood plasma was collected from all study participants at birth (day of life (DOL) 0) and at one follow-up time point at DOL 1, 3, or 7. Plasma cytokine and chemokine concentrations were measured by bead-based cytokine multiplex assay. Unsupervised clustering was used to identify patterns in plasma cytokine and chemokine ontogeny during early life. Results: We observed an increase across the first week of life in plasma Th1 cytokines such as IFNγ and CXCL10 and a decrease in Th2 and anti-inflammatory cytokines such as IL-6 and IL-10, and chemokines such as CXCL8. In contrast, other cytokines and chemokines (e.g. IL-4 and CCL5, respectively) remained unchanged during the first week of life. This robust ontogenetic pattern did not appear to be affected by gestational age or sex. Conclusions: Ontogeny is a strong driver of newborn plasma-based levels of cytokines and chemokines throughout the first week of life with a rising IFNγ axis suggesting post-natal upregulation of host defense pathways. Our study will prove useful to the design and interpretation of future studies aimed at understanding the neonatal immune system during health and disease.